转化生殖科学进展:睾丸组织移植与体外精子发生
本文综述了针对无法产生功能性精子的男性恢复精子发生的实验性疗法,包括自体(干细胞移植、新生形态发生、睾丸组织移植)和体外(异种移植、体外精子发生)方法,这些方法在动物模型中显示出不同程度成功,部分技术可能在近十年内进入人体试验和临床。
要点
- 男性无功能性精子时目前无生育选择,实验性疗法在动物模型中显示希望。
- 自体方法包括干细胞移植、新生形态发生和睾丸组织移植。
- 体外方法包括异种移植和体外精子发生。
核心结论
- 多种实验性技术可在动物模型中恢复精子发生,部分可能在未来十年内临床实施。
研究设计与样本
- 综述总结了自体(干细胞移植、新生形态发生、睾丸组织移植)和体外(异种移植、体外精子发生)方法在动物模型中的研究进展。
主要发现
- 自体与体外方法在恢复不育动物精子发生方面取得不同程度成功。
临床怎么用
- 目前无生育选择的无功能性精子男性,未来可能受益于这些实验性技术。
局限性
- 技术尚未在人类中建立安全性和有效性,需确定理想患者人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Since the birth of the first child conceived via in vitro fertilization 40 years ago, fertility treatments and assisted reproductive technology have allowed many couples to reach their reproductive goals. As of yet, no fertility options are available for men who cannot produce functional sperm, but many experimental therapies have demonstrated promising results in animal models. Both autologous (stem cell transplantation, de novo morphogenesis, and testicular tissue grafting) and outside-the-body (xenografting and in vitro spermatogenesis) approaches exist for restoring sperm production in infertile animals with varying degrees of success. Once safety profiles are established and an ideal patient population is chosen, some of these techniques may be ready for human experimentation in the near future, with likely clinical implementation within the next decade.
引用
- Pelzman DL, Orwig KE, Hwang K, et al. Progress in translational reproductive science: testicular tissue transplantation and in vitro spermatogenesis. Fertil Steril. 2020. PMID: 32111477. doi:10.1016/j.fertnstert.2020.01.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。